Esther Papaseit
Biographic Data
| ID | 7336777 |
|---|---|
| NAME | Esther Papaseit |
| GIVEN NAMES | Esther |
| FAMILY NAME | Papaseit |
| SIGNATURE | PAPASEIT E |
| AFFILIATIONS | Universitat Autonòma de Barcelona |
| ORCID | 0000-0003-2620-4274 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Synthetic cannabinoids use in a sample of opioid-use disorder patients
Cannabis is the most widely consumed illegal drug in the world and synthetic cannabinoids are increasingly gaining popularity and replacing traditional cannabis. These substances are a type of new psychoactive substance that mimics the cannabis effects but often are more severe. Since, people with opioids use disorder use widely cannabis, they are a population vulnerable to use synthetic cannabinoids. In addition, these substances are not detecte…
BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression
Results suggest a different pathogenesis for CUD-induced-MDD with higher levels of cortisol and BDNF compared with CUD-primary-MDD. Such variations should imply different approaches in treatment
Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries
Background: Non-medical use (NMU) of prescription GABA analogs (pregabalin and gabapentin) has been reported especially in opiate dependent persons. However, by now the prevalence of NMU of gabapentinoids in the general population has not been sufficiently evaluated. The aim of this research paper is to determine the prevalence of prescription GABA analog NMU and associated demographics in five European countries with special detail of Spain. Met…
No prominent works on this page.
Non-medical Use of Prescription Gabapentinoids (Gabapentin and Pregabalin) in Five European Countries
Background: Non-medical use (NMU) of prescription GABA analogs (pregabalin and gabapentin) has been reported especially in opiate dependent persons. However, by now the prevalence of NMU of gabapentinoids in the general population has not been sufficiently evaluated. The aim of this research paper is to determine the prevalence of prescription GABA analog NMU and associated demographics in five European countries with special detail of Spain. Met…
Synthetic cannabinoids use in a sample of opioid-use disorder patients
Cannabis is the most widely consumed illegal drug in the world and synthetic cannabinoids are increasingly gaining popularity and replacing traditional cannabis. These substances are a type of new psychoactive substance that mimics the cannabis effects but often are more severe. Since, people with opioids use disorder use widely cannabis, they are a population vulnerable to use synthetic cannabinoids. In addition, these substances are not detecte…
BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression
Results suggest a different pathogenesis for CUD-induced-MDD with higher levels of cortisol and BDNF compared with CUD-primary-MDD. Such variations should imply different approaches in treatment
Medicine (3 works) · Psychiatry (3 works) · Environmental health (2 works) · Pharmacology (2 works) · Population (2 works) · Addiction (1 works) · Alternative medicine (1 works) · Anesthesia and Sedative Agents (1 works) · Cannabinoid (1 works) · Cannabis (1 works)